Skip Navigation
Skip to contents

2021 KAPAPD-APAPARI Joint Congress

2021 KAPARD-APAPARI Joint Congress
Korean Academy of Pediatric Allergy and respiratory Disease
The Asia Pacific Association of Pediatric Allergy, Respirology & Immunology
Date : May 20(Thu) ~ 22 (Sat), 2021
Venue : Swiss Grand Hotel, Seoul, Korea

Scientific Program

Page Path
Home Program Scientific Program
Time Sessions Speakers
08:30-10:00 Plenary 1: Update in AD
1. Multi-omic evaluation of atopic dermatitis in children Donald YM Leung (USA)
2. Biologics for the management of atopic dermatitis in the era of precision medicine Emma Guttman-Yassky (USA)
3. Can we prevent development of atopic dermatitis and atopic march? Hugo van Bever (Singapore)
10:00-10:30 Coffee Break
10:30-12:00 Symposium 1: Food allergy in Asia Pacific
1. Anaphylaxis in children and adolescents: Data from the APAPARI Anaphylaxis Registry Agnes Leung (HK)
2. Seed and nut allergies in children Kyunguk Jeong (Korea)
3. Epicutaneous sensitization to food allergens: What do we know and what should we do? Punchama Pacharn (Thailand)
10:30-12:00 Symposium 2: Pediatric asthma in Asia
1. Pediatric asthma in Asia: Phenotypes and endotypes Dong-In Suh (Korea)
2. Biomarkers in pediatric asthma: Pathophysiologic basis and clinical implications Myung Hyun Sohn (Korea)
3. Biologics for the treatment of pediatric asthma: Which, who and when? Jiu-Yao Wang (Taiwan)
10:30-12:00 Oral presentation 1
12:00-13:00 Luncheon symposium
14:00-15:30 Plenary 2: Update in the management of food allergy
1. New perspectives in diagnosis of food allergy Sooyoung Lee (Korea)
2. Recent advances in immunotherapy of food allergy: Efficacy, safety and long-term follow-up Motohiro Ebisawa (Japan)
3. Primary prevention of food allergy: Experiences in Asia Bee Wha Lee (Singapore)
15:30-16:00 Coffee Break
16:00-17:30 Symposium 3: New concepts in AD
1. Are there distinct phenotypes of AD in Asian children? Yukihiro Ohya (Japan)
2. Immunologic profiles of Asian patients with AD Emma Guttman-Yassky (USA)
3. Noninvasive evaluation of protein and lipid compositions in AD skin Jihyun Kim (Korea)
16:00-17:30 Symposium 4: Pathophysiology and management of rhinosinusitis
1. The role of microbiome in upper airway disease Ruby Pawankar (Japan)
2. Climate Change and Allergic Rhinitis in India Anand B. Singh (India)
3. Clinical practice on pediatric chronic rhinosinusitis Yong Mean Park (Korea)
16:00-17:30 Oral presentation 2
17:30-20:00 Opening Ceremony & Welcome Reception
Time Sessions Speakers
08:30-10:00 Plenary 3. New concepts in pediatric asthma
1. Prediction and prevention of pediatric asthma: What we learned from birth cohort studies. Soo Jong Hong (Korea)
2. Multi-Omics approach to pathogenesis of pediatric asthma James Gern (USA)
3. Phenotypes and precision medicine in severe asthma in children Ioana Agache (Romania)
10:00-10:30 Coffee Break
10:30-12:00 Symposium 5: Indoor and outdoor pollution
1. Air pollution and epigenetic changes: Effects on asthma Hyo Bin Kim (Korea)
2. Particulate matter does matter in childhood asthma Dae Jin Song (Korea)
3. Air pollution and oxidative stress: Immunologic impact on allergic rhinitis
10:30-12:00 Symposium 6: immunotherapy in real practice
1. Oral immunotherapy in the office setting Pantipa Chatchatee (Thailand)
2. How to optimize immunotherapy for multiple pollen allergy? Dae Hyun Lim (Korea)
3. Subcutaneous immunotherapy vs sublingual immunotherapy in children Elizabeth Tham (Singapore)
10:30-12:00 Oral presentation 3
12:00-13:00 Luncheon symposium
13:00-14:00 Pros & Cons: Early moisturizing can prevent eczema?
14:00-15:30 Plenary 4: Environment, exposome and allergic diseases in Asia
1. Global warming and allergic diseases in Asia Pacific region: What will happen in the next 30 years? Gary Wong (Hong Kong)
2. Future prospects in Asia: Impact of climate change and air pollution on pollinosis Jae Won Oh (Korea)
3. Exposome research: Long-term exposure to the environment and allergic diseases Young J Juhn (USA)
15:30-16:00 Coffee Break
16:00-17:30 Symposium 7: Ongoing birth cohort studies of allergic diseases
1. What's different from western countries?: A2BC network in Asia Naoki Shimojo (Japan)
2. Lessons from US birth cohort consortium for the research of allergic diseases James Gern (USA)
3. Early-life environmental determinants of allergic diseases in the US
16:00-17:30 Symposium 8: Itch and chronic urticaria in children
1. Updates in mechanism and biomarkers of pruritus Ellis Hon (Hong Kong)
2. Prevalence and causes of chronic urticaria in Asia Pacific Wasu Kamchaisatian (Thailand)
3. Management and prognosis of chronic spontaneous urticaria in children Taek Ki Min (Korea)
16:00-17:30 Oral presentation 4
19:00-22:00 Faculty Dinner
Time Sessions Speakers
08:30-10:00 Plenary 5: Updates in pediatric lung diseases
1. Management and prognosis of interstitial lung disease in children Andrew Bush (UK)
2. Approach to apnea in infants and children Daniel K. Ng (Hong Kong)
3. Therapy for mucus clearance disorders - drugs and devices Bruce Rubin (USA)
10:00-10:30 Coffee Break
10:30-12:00 Symposium 9: Pediatric respiratory and critical care
1. Flexible bronchoscopy for the diagnosis and treatment of pediatric respiratory diseases Daniel K. Ng (Hong Kong)
2. ICU rehabilitation for children with respiratory failure Joongbum Cho (Korea)
3. Preparing for the pediatric lung transplantation: When and How? Jinho Yu (Korea)
10:30-12:00 Symposium 10: Multiomic approaches in allergic diseases: Experiences in Asia
1. Lessons from genomic studies in asthma and allergic diseases Kyung Won Kim (Korea)
2. Updates in the role of microbiome in atopic dermatitis Ting Fan Leung (Hong Kong)
3. Application of metabolomics in allergic diseases
10:30-12:00 Oral presentation 5
12:00-13:00 Luncheon symposium
13:00-14:00 Pros & Cons: Should we stop prescribing short acting beta-agonist for mild asthma? Gary Wong (Hong Kong), Andrew Bush (UK)
14:00-15:30 Symposium 11: Lessons from COVID-19 pandemic
1. Clinical manifestations and pathogenesis of COVID-19: differences between children and adults Eun Hwa Choi (Korea)
2. Challenges in allergic diseases: COVID-19 pandemic era Kunling Shen (China)
3. Immunopathogenesis of coronavirus infections: SARS and COVID-19 Yu-Lung Lau (Hong Kong)
14:00-15:30 Symposium 12: Understanding of allergic march
1. Development of food allergy in children with atopic dermatitis: Cellular and molecular mechanism Donald YM Leung (USA)
2. Developmental relationship between AD and allergic airway diseases: Evidence from birth cohorts Eun Lee (Korea)
3. Identification of allergic march phenotypes and endotypes: Multiomics Biomarker Ioana Agache (Romania)
14:00-15:30 Oral presentation 6
15:30-16:00 Coffee Break
16:00-17:30 Symposium 13: APSID symposium: Recent updates in primary immunodeficiency
1. Auto-inflammatory disorders - our experience at Chandigarh, India Surjit Singh (India)
2. Monogenic autoimmune diseases Huawei Mao (China)
3. Lessons learned from Bruton Hirokazu Kanegane (Japan)
16:00-17:30 Symposium 14: WAO symposium
will be updated
16:00-17:30 Symposium 15: Respiratory tract infections and antibiotics in children
1. Nationwide survey of pneumococcus serotypes in pediatric pneumonia Takao Fujisawa (Japan)
2. Macrolide-resistant Mycoplasma pneumoniae in children Hyun Jong Yang (Korea)
3. Immune modulation by macrolide antibiotics: More than killing bugs Bruce Rubin (USA)
17:30-18:00 Closing Ceremony
ⓒ Korean Academy of Pediatric Allergy and Respiratory Disease
  • President, Organizing Committee : Soo-Jong Hong
  • Business License No. : 213-82-08787
Congress Secretariat [The Within]

[04038] 5F, Samgyeong Bldg., #100-20, Yanghwa-ro, Mapo-gu, Seoul, Korea